ArticleThe open cardiovascular medicine journal2011

Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment.

Vasilios G Athyros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.